← Screener

ZTSZoetis

Health care · Pharmaceuticals · NYSE

Compare with peers → Embed

Filings with the SEC since Feb 19, 2020

1,004 filings, 12 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 12, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Nov 5, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 5, 2026

8-K: Quarterly results

Filed in the last 30 days

of 1,004 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 40 events

Nov 5, 20268-K Quarterly results 8-K item 2.02
Nov 5, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Oct 13, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Oct 8, 20268-K Regulation FD disclosure 8-K item 7.01
Aug 6, 2026Officer CFO and COO change Appointment of James Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer
Aug 6, 20268-K Quarterly results 8-K item 2.02
Aug 6, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
May 22, 20268-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
May 20, 20268-K Regulation FD disclosure 8-K item 7.01
May 13, 2026Buy Bisaro Paul (Director) bought $152K open-market purchase on May 13, 2026
May 13, 2026Buy DAMELIO FRANK A (Director) bought $501K open-market purchase on May 13, 2026
May 13, 2026Cluster buy Cluster buy: 3 insiders bought $886K 2026-05-11 to 2026-05-13: DAMELIO FRANK A, MCCALLISTER MICHAEL B, Bisaro Paul
May 12, 2026Buy MCCALLISTER MICHAEL B (Director) bought $233K open-market purchase on May 11, 2026
May 7, 20268-K Quarterly results 8-K item 2.02
May 7, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Feb 12, 20268-K Quarterly results 8-K item 2.02
Feb 12, 202610-K Annual report (10-K) period ended Dec 31, 2025
Feb 5, 20268-K Regulation FD disclosure 8-K item 7.01
Dec 18, 20258-K Material agreement signed, New debt or obligation, Unregistered share sale, Regulation FD disclosure 8-K items 1.01, 2.03, 3.02, 7.01
Dec 11, 20258-K Regulation FD disclosure 8-K item 7.01
Dec 2, 20258-K Other events 8-K item 8.01
Nov 4, 20258-K Quarterly results 8-K item 2.02
Nov 4, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Oct 28, 20258-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Oct 9, 20258-K Regulation FD disclosure 8-K item 7.01
Aug 27, 20258-K Material agreement signed, Material agreement ended, New debt or obligation 8-K items 1.01, 1.02, 2.03
Aug 18, 20258-K Other events 8-K item 8.01
Aug 5, 2025Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We may from time to time offer to sell debt securities, common stock, preferred stock, warrants, depositary shares, purchase contracts, purchase units, guarantees of debt securities or hybrid securities combining elements of the foregoing.
Aug 5, 20258-K Quarterly results 8-K item 2.02
Aug 5, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
May 22, 20258-K Director or officer change, Shareholder vote results 8-K items 5.02, 5.07
May 21, 20258-K Regulation FD disclosure 8-K item 7.01
May 6, 20258-K Quarterly results 8-K item 2.02
May 6, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Feb 13, 20258-K Quarterly results 8-K item 2.02
Feb 13, 202510-K Annual report (10-K) period ended Dec 31, 2024
Feb 6, 20258-K Regulation FD disclosure 8-K item 7.01
Jan 13, 20258-K Regulation FD disclosure 8-K item 7.01
Dec 12, 20248-K Regulation FD disclosure 8-K item 7.01
Nov 12, 20248-K Change in control, Other events 8-K items 5.01, 8.01

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1004 Annual & quarterly 27 Current reports (8-K) 85 Insiders 826 Proxy & votes 20 Big owners (13D/13G) 13 Shares & debt offered 12 SEC letters 3 Other 18

Filed	Form	What it is	Period
Apr 8, 2026	DEFA14A	Extra proxy material		all files
Apr 8, 2026	DEF 14A	Proxy statement	Dec 31, 2025	all files
Apr 9, 2025	DEFA14A	Extra proxy material		all files
Apr 9, 2025	DEF 14A	Proxy statement	May 21, 2025	all files
May 8, 2024	DEFA14A	Extra proxy material		all files
May 6, 2024	DEFA14A	Extra proxy material		all files
Apr 10, 2024	DEFA14A	Extra proxy material		all files
Apr 10, 2024	DEF 14A	Proxy statement	May 22, 2024	all files
Mar 27, 2024	PRE 14A		May 22, 2024	all files
Apr 12, 2023	PX14A6G	Shareholder's proxy letter		all files
Apr 6, 2023	DEFA14A	Extra proxy material		all files
Apr 6, 2023	DEF 14A	Proxy statement		all files
Mar 22, 2023	PRE 14A			all files
Apr 6, 2022	DEFA14A	Extra proxy material		all files
Apr 6, 2022	DEF 14A	Proxy statement	May 19, 2022	all files
Mar 18, 2022	PRE 14A		May 19, 2022	all files
Apr 6, 2021	DEFA14A	Extra proxy material		all files
Apr 6, 2021	DEF 14A	Proxy statement	May 20, 2021	all files
Apr 6, 2020	DEFA14A	Extra proxy material		all files
Apr 6, 2020	DEF 14A	Proxy statement	May 20, 2020	all files

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →